Obesity-induced changes in adipokine secretion can modify the adipose tissue-liver crosstalk [31,32] and the ratio between leptin and adiponectin has been proposed as a superior biomarker of NAFLD than adiponectin or leptin measurements alone [33,34]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.